|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.71 INR | -4.63% |
|
+12.36% | +45.39% |
| Market Cap | 18.52B 195M 170M 156M 146M 276M 281M 1.88B 728M 9.08B 730M 715M 31.3B | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 18.52B 195M 170M 156M 146M 276M 281M 1.88B 728M 9.08B 730M 715M 31.3B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
57.31% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | -4.63% | ||
| 1 week | +12.36% | ||
| Current month | +0.95% | ||
| 1 month | +30.34% | ||
| 3 months | +57.21% | ||
| 6 months | +42.20% | ||
| Current year | +45.39% |
| 1 week | 52.49 |  | 63.4 |
| 1 month | 42.52 | | 63.4 |
| Current year | 33.44 | | 63.4 |
| 1 year | 33.44 | | 66.36 |
| 3 years | 28.51 | | 100.8 |
| 5 years | 23.65 | | 100.8 |
| 10 years | 7.21 | | 100.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CEO | Chief Executive Officer | 62 | 1992-01-31 |
| Director of Finance/CFO | 59 | 2002-04-02 | |
| Compliance Officer | 40 | 2018-11-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 1992-01-31 |
Sanjay Suri
BRD | Director/Board Member | 57 | 2019-08-12 |
| Director/Board Member | 57 | 2019-08-12 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.63% | +12.36% | -3.24% | +96.87% | 361M | |
| +1.86% | +7.65% | +55.77% | +158.84% | 1,063B | |
| +3.57% | +7.42% | +69.09% | +58.92% | 611B | |
| +3.99% | +7.37% | +36.87% | +93.77% | 444B | |
| -1.20% | -1.94% | +26.41% | +20.22% | 324B | |
| +4.94% | +3.39% | +39.92% | +28.93% | 285B | |
| +2.42% | +1.60% | +30.06% | +42.24% | 283B | |
| +2.47% | +5.18% | -24.80% | -39.60% | 219B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 195B | |
| +4.21% | +6.00% | +17.72% | +70.33% | 156B | |
| Average | +1.65% | +5.87% | +27.38% | +59.90% | 358.11B | |
| Weighted average by Cap. | +1.85% | +5.08% | +41.54% | +80.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.02B 179M 156M 143M 134M 254M 258M 1.73B 669M 8.35B 671M 657M 28.76B | 18.12B 190M 166M 153M 142M 270M 274M 1.84B 712M 8.89B 715M 699M 30.62B |
| Net income | 962M 10.1M 8.83M 8.1M 7.56M 14.33M 14.57M 97.58M 37.82M 472M 37.93M 37.1M 1.63B | 1.18B 12.4M 10.83M 9.95M 9.28M 17.59M 17.88M 120M 46.42M 579M 46.55M 45.54M 1.99B |
| Net Debt | 121M 1.27M 1.11M 1.02M 947K 1.8M 1.83M 12.23M 4.74M 59.12M 4.75M 4.65M 204M | -928K -9.75K -8.52K -7.82K -7.29K -13.83K -14.06K -94.17K -36.5K -455K -36.6K -35.81K -1.57M |
Employees
1,814
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | ₹59.71 | -4.63% | 787,369 |
| 26-07-01 | ₹62.61 | +5.85% | 2,026,137 |
| 26-06-30 | ₹59.15 | +8.29% | 2,759,568 |
| 26-06-29 | ₹54.62 | +2.79% | 817,986 |
| 26-06-25 | ₹53.14 | +2.07% | 748,285 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
